IL-17 receptor A antigen binding proteins

The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or mor...

Full description

Saved in:
Bibliographic Details
Main Authors Smothers, James F, FITZPATRICK, David, Peschon, Jacques J, TOCKER, Joel, LIM, Ai Ching, MEHLIN, Christopher
Format Patent
LanguageEnglish
Hungarian
Published 28.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
AbstractList The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
Author LIM, Ai Ching
FITZPATRICK, David
MEHLIN, Christopher
Smothers, James F
Peschon, Jacques J
TOCKER, Joel
Author_xml – fullname: Smothers, James F
– fullname: FITZPATRICK, David
– fullname: Peschon, Jacques J
– fullname: TOCKER, Joel
– fullname: LIM, Ai Ching
– fullname: MEHLIN, Christopher
BookMark eNrjYmDJy89L5WTQ9PTRNTRXKEpNTi0oyS9ScFRIzCvJTE_NU0jKzEvJzEtXKCjKL0nNzCvmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxHqGuBsbGRoZmISFGxsSoAQB9JioE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate IL-17-receptor-A-antigénhez kötõdõ fehérjék
ExternalDocumentID HUE033216TT2
GroupedDBID EVB
ID FETCH-epo_espacenet_HUE033216TT23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:48 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Hungarian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HUE033216TT23
Notes Application Number: HUE12159091
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171128&DB=EPODOC&CC=HU&NR=E033216T2
ParticipantIDs epo_espacenet_HUE033216TT2
PublicationCentury 2000
PublicationDate 20171128
PublicationDateYYYYMMDD 2017-11-28
PublicationDate_xml – month: 11
  year: 2017
  text: 20171128
  day: 28
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies Kirin-Amgen Inc
RelatedCompanies_xml – name: Kirin-Amgen Inc
Score 3.1149824
Snippet The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title IL-17 receptor A antigen binding proteins
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171128&DB=EPODOC&locale=&CC=HU&NR=E033216T2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTkXnhQhS8CFomvX2UMT1QhV3QVrZ2zBLx_oyi-3w73sSWvVF30ICJ8mBc_mSnC8A13zpLTBt5dTyPEkHUnL6JrmgCA1yV2LA8PSvJaOxnWSDp5k160DR1sJontBPTY6IFrVAe6-1vy5_DrFC_bayuhUFdr3fx6kfGg06Zg6mD64RDv1oOgkngREEfpIZ4xc_uuPcZHaK3noLs2hHGUP0OlRFKeXviBLvw_YUha3rA-isNj3YDdqP13qwM2ruu7HZmF51CDePz5Q5BB1UXiJOJg8EdaKoNIkodGUK0ZQLxbo6gqs4SoOE4pzz7_3Nk6xdXWryY-gi7s9PgPClELghqQhbEFaYLmPCdmTOJKY0HrNOof-3nP5_g2ewp3SlSupM9xy69ccmv8DYWotLrZUv75N8RA
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq6L1FUECHoJutnkdgtg8SDVJiyTSW3C7KeZSg0nx7ztZEvWit2UX9jEwj2935xuAa7qylhi2UkWzLK6MOafKK6dMQWiQmxwdhiWqlkSxHqTjx4W26EHR5cIIntBPQY6IGrVEfa-FvS5_LrFc8beyumUFdr3f-4ntyi06JgaGD6bsTmxvPnNnjuw4dpDK8bPt3VGqEj1Ba72FEbbZFDvwXiZNUkr526P4e7A9x8nW9T703jZDGDhd4bUh7ETtezc2W9WrDuBmGirEkNBA5SXiZOlBQpk0VJoSK0RmiiQoF4p1dQhXvpc4gYJrZt_ny4K0212i0iPoI-7Pj0GiK8bwQLwhbEFYoZqEMN3gOeEY0lhEO4HR3_OM_hu8hEGQRGEWTuOnU9ht5Nak16nmGfTrj01-jn62ZhdCQl_qr380
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IL-17+receptor+A+antigen+binding+proteins&rft.inventor=Smothers%2C+James+F&rft.inventor=FITZPATRICK%2C+David&rft.inventor=Peschon%2C+Jacques+J&rft.inventor=TOCKER%2C+Joel&rft.inventor=LIM%2C+Ai+Ching&rft.inventor=MEHLIN%2C+Christopher&rft.date=2017-11-28&rft.externalDBID=T2&rft.externalDocID=HUE033216TT2